As the U.S. Food and Drug Administration’s Center for Veterinary Medicine continues to progress in implementation of its Animal and Veterinary Innovation Agenda, the center is supporting a collaborative agreement to the Reagan-Udall Foundation for the FDA (the Foundation) to conduct a strengths, weaknesses, opportunities, and threats (SWOT) analysis. This SWOT analysis aims to research the challenges within, and unmet needs of, the animal health, animal food and veterinary industries, and explain the economic impact of these gaps.
To conduct the analysis, the Foundation has convened a panel of experts to perform a comprehensive analysis of the U.S. animal and veterinary industries.
The Foundation plans to share the outcome of its research publicly, once completed. The FDA looks forward to utilizing these findings to further its work in spurring and supporting innovation in the animal and veterinary industries.
This effort is part of CVM’s implementation of the Animal and Veterinary Innovation Agenda, released in September 2023, which describes numerous ways the FDA wants to foster, spur, and support innovation in the veterinary and animal industries.
For more information
FDA Animal and Veterinary Innovation Agenda
[Source: FDA CVM 18 September 2024]